What are the benefits of therapeutic drug monitoring in the optimization of adalimumab therapy? a systematic review and meta-analysis up to 2022

• Autors principals: Yun Li (Autor), Cheng Xie (Autor), Xiaoliang Ding (Autor), Ziyang Wu (Autor), Jingjing Zhang (Autor), Jianguo Zhu (Autor), Liyan Miao (Autor)
• Format: Llibre
• Publicat: Frontiers Media S.A., 2024-07-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

AimsPersistent uncertainties exist surrounding the therapeutic drug monitoring (TDM) of adalimumab in clinical settings. To address these issues, we conducted a systematic review to assess the current evidence regarding the benefits of TDM for adalimumab.MethodsPubMed, EMBASE, and Cochrane Databases...